Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective, Observational and Cohort Clinical Research on Clinical Efficacy and Safety of Different Doses of Micafungin Sodium for Injection in Prevention and Treatment of Fungal Infection in Patients With Hematological Tumors

NCT04738955 is registered in ClinicalTrials.gov with Shandong Provincial Hospital as lead sponsor.

NCT NCT04738955
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04738955 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective, Observational and Cohort Clinical Research on Clinical Efficacy and Safety of Different Doses of Micafungin Sodium for Injection in Prevention and Treatment of Fungal Infection in Patients With Hematological Tumors
Lead sponsor
Shandong Provincial Hospital
Phase
Phase 4
Overall status
Unknown status
Start date
February 1, 2021
Completion date
October 1, 2023
Enrollment
230 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hematological tumors patients with high risk factors of invasive fungal disease